Suppression of protein kinase C theta contributes to enhanced myogenesis In vitro via IRS1 and ERK1/2 phosphorylation

Joseph S. Marino, Terry D. Hinds, Rachael A. Potter, Eric Ondrus, Jeremy L. Onion, Abigail Dowling, Thomas J. McLoughlin, Edwin R. Sanchez, Jennifer W. Hill

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Background: Differentiation and fusion of skeletal muscle myoblasts into multi-nucleated myotubes is required for neonatal development and regeneration in adult skeletal muscle. Herein, we report novel findings that protein kinase C theta (PKCθ) regulates myoblast differentiation via phosphorylation of insulin receptor substrate-1 and ERK1/2.Results: In this study, PKCθ knockdown (PKCθshRNA) myotubes had reduced inhibitory insulin receptor substrate-1 ser1095 phosphorylation, enhanced myoblast differentiation and cell fusion, and increased rates of protein synthesis as determined by [3H] phenylalanine incorporation. Phosphorylation of insulin receptor substrate-1 ser632/635 and extracellular signal-regulated kinase1/2 (ERK1/2) was increased in PKCθshRNA cells, with no change in ERK5 phosphorylation, highlighting a PKCθ-regulated myogenic pathway. Inhibition of PI3-kinase prevented cell differentiation and fusion in control cells, which was attenuated in PKCθshRNA cells. Thus, with reduced PKCθ, differentiation and fusion occur in the absence of PI3-kinase activity. Inhibition of the ERK kinase, MEK1/2, impaired differentiation and cell fusion in control cells. Differentiation was preserved in PKCθshRNA cells treated with a MEK1/2 inhibitor, although cell fusion was blunted, indicating PKCθ regulates differentiation via IRS1 and ERK1/2, and this occurs independently of MEK1/2 activation.Conclusion: Cellular signaling regulating the myogenic program and protein synthesis are complex and intertwined. These studies suggest that PKCθ regulates myogenic and protein synthetic signaling via the modulation of IRS1and ERK1/2 phosphorylation. Myotubes lacking PKCθ had increased rates of protein synthesis and enhanced myotube development despite reduced activation of the canonical anabolic-signaling pathway. Further investigation of PKCθ regulated signaling may reveal important interactions regulating skeletal muscle health in an insulin resistant state.

Original languageEnglish
Article number39
JournalBMC Cell Biology
Volume14
Issue number1
DOIs
StatePublished - Sep 21 2013

Bibliographical note

Funding Information:
The authors thank Francis X. Pizza (UT-Main Campus) for technical advice, and Lance Stechschulte, and Leah Wuescher (UT-College of Medicine) for technical assistance. The authors would like to thank Susan Tsivitse Arthur (UNC Charlotte) for critical review of this manuscript. This work was supported by the University of Toledo deArce-Koch award to JWH.

Funding

The authors thank Francis X. Pizza (UT-Main Campus) for technical advice, and Lance Stechschulte, and Leah Wuescher (UT-College of Medicine) for technical assistance. The authors would like to thank Susan Tsivitse Arthur (UNC Charlotte) for critical review of this manuscript. This work was supported by the University of Toledo deArce-Koch award to JWH.

FundersFunder number
University of Toledo deArce-Koch
National Institute of Diabetes and Digestive and Kidney DiseasesP30DK020572

    Keywords

    • Insulin receptor substrate
    • Myoblast differentiation
    • Myoblast fusion
    • Protein kinase C

    ASJC Scopus subject areas

    • Cell Biology

    Fingerprint

    Dive into the research topics of 'Suppression of protein kinase C theta contributes to enhanced myogenesis In vitro via IRS1 and ERK1/2 phosphorylation'. Together they form a unique fingerprint.

    Cite this